公开(公告)号：US11492396B2

公开(公告)日：2022-11-08

申请号：US15771310

申请日：2016-10-26

Applicant: UCB BIOPHARMA SPRL

Inventor： Sophie Glatt ,  Lucian Ionescu ,  Margaret Jones ,  Ruth Oliver ,  Stevan Graham Shaw ,  Foteini Strimenopoulou ,  Venkata Pavan Kumar Vajjah

IPC: A61K39/395 ,  C07K16/24 ,  A61P17/06 ,  A61P19/02 ,  A61K39/00

Abstract: The invention relates to therapeutic uses of antibody molecules having specificity for antigenic determinants of both IL-17A and IL-17F in the treatment of dermatological and rheumatological diseases, such as psoriasis, psoriatic arthritis and axial spondyloarthritis.

公开(公告)号：US20190292255A1

公开(公告)日：2019-09-26

申请号：US15771310

申请日：2016-10-26

Applicant: UCB BIOPHARMA SPRL

Inventor： Sophie Glatt ,  Lucian Ionescu ,  Margaret Jones ,  Ruth Oliver ,  Stevan Graham Shaw ,  Foteini Strimenopoulou ,  Venkata Pavan Kumar Vajjah

IPC: C07K16/24 ,  A61P19/02 ,  A61P17/06

Abstract: The invention relates to therapeutic uses of antibody molecules having specificity for antigenic determinants of both IL-17A and IL-17F in the treatment of dermatological and rheumatological diseases, such as psoriasis, psoriatic arthritis and axial spondyloarthritis.